Clinical Trial Update: Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes Phase 1/Phase 2 evaluation of Caphosol to reduce oral mucositis in patients undergoing radiation therapy for head and neck …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Caphosol

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Oral Mucositis | Phase 1, Phase 2 | Status: UNKNOWN